Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
At 2.5 mg/mL, every standard dose fits within a 100-unit syringe
Sorli C, Harashima S ichi, Tsoukas GM, Unger J, Karsbl JD, Hansen T, et al
The STEP 1 trial extension study, published in Diabetes, Obesity and Metabolism , found that participants who discontinued semaglutide after 68 weeks regained approximately two-thirds of their lost weight within one year of stopping treatment
3 Takeaways from the Landmark Oral GLP-1 'Switch' Trial for Obesity Care The Weight Maintenance Challenge As clinicians on the front lines of obesity medicine, we are intimately familiar with the central challenge our patients face: sustaining weight loss after a period of initial success
